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AblationAbstract Purpose: To demonstrate our experience in percutaneous radiofrequency ablation
(RFA) as a minimally invasive therapy for patients with osteoid osteoma.
Patients and methods: We will highlight cases of osteoid osteoma treated by minimally invasive
therapy (RFA) and the role of image guidance in making the procedure rapid outpatient service
instead of hospitalization and morbidity of open surgery. This will include 15 patients (10 males
& 5-females) aged 12–35 years, (mean 20), their clinical and radiological diagnosis was osteoid
osteoma. All patients were treated by CT guided percutaneous RFA under spinal and epidural
anesthesia.
Results: 14 (93.3%) of the 15-patients had prompt improvement of clinical symptoms and pain
relief, one patient underwent second session of re-ablation. The mean follow-up period was
12 months and no patient had pain recurrence.
Conclusion: Percutaneous RFA is a safe and effective minimally invasive outpatient treatment for
osteoid osteoma with low cost, low morbidity, better quality of life when compared with open sur-
gery.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osteoid osteoma is a small, benign painful bone forming lesion
with speciﬁc clinical and imaging characteristics. Ninety per-
cent of cases arise before the age of 30 years, with male pre-
dominance. The proximal femur and tibia are the most
common sites to be affected (1).
In Mayo Clinic a review of 11087 primary bone tumors that
were subjected to either biopsy or complete surgical resection,
osteoid osteoma accounted for 13.5% of all benign tumors (2).
Table 1 Shows clinical manifestations in patients with osteoid
osteoma.
Pain and medications Responding Not responding
4 patients 11 patients
Movement limitation Limited in Not limited in
8 patients 7 patients
Muscle wasting Present in Not evident in
5 patients 10 patients
Table 2 Shows location and architecture of the nidus (size,
sclerosis, and cortical reaction).
Lesion location Proximal femur Proximal tibia
11 patients 4 patients
Nidus Visible in radiograph Size
14 7–10 mm
Sclerosis Dense sclerosis in Scanty sclerosis in
13 patients 2 patients
Cortical reaction Marked in Mild in
10 patients 5 patients
Table 3 Shows clinical and radiological improvement in
patient post RF ablation of osteoid osteoma.
One month 6 months 12 months
Pain 14 improve 1 persist 15 improve 15 improve
Cavity Persist Partial ﬁlling Partial ﬁlling
Sclerosis Persist Reduced Markedly reduced
Fractures No No No
950 M.M.M. Elian, A.F. SadekThe most common symptom is bone pain, which often
worsens at night and is usually dramatically relieved by aspirin
or other non-steroidal anti-inﬂammatory drugs. Pain initially
may be described as a dull aching pain which may progress
to severe localized pain over the site of the tumor. It may cause
arousal from sleep, with resultant sleep deprivation. Less com-
mon manifestations of osteoid osteoma include growth distur-
bance, bone deformity, and painful scoliosis in spinal lesions.
If the lesion is located within a joint capsule, it may cause joint
swelling, synovitis, effusion and restricted mobility. Despite
medical therapy, many patients have residual discomfort
related to their osteoid osteoma (3).
Radiologically, the lesion is consisted of a small rounded
radiolucency called nidus, which is surrounded by dense, reac-
tive new bone. The nidus is often obscured on radiographs by
reactive bone. Computed tomography (CT) is the best modal-
ity to delineate the bony architecture of osteoid osteoma. The
nidus is characteristically less than 10 mm in diameter.
Technetium-99M HDP bone scintigraphy typically reveals
intense focal radiotracer uptake in the lesion. MDCT and
magnetic resonance imaging help differentiate between osteoid
osteoma and infection (4).
In the past several methods have been used to treat osteoid
osteoma, these included medical management with non-
steroidal anti-inﬂammatory drugs (5) and open surgical resec-
tion with wide surgical margins. Precise intraoperative local-
ization of the nidus is the most crucial point and is
considered the surgical difﬁculty, which often requires wide
bone resection to ensure adequate treatment. This has resulted
in signiﬁcant surgical morbidity, intraoperative and early post-
operative pathological fracture in many cases. Percutaneous
radiofrequency ablation (RFA) for osteoid osteoma was ﬁrst
reported by Rosenthal et al. in 1992 (6), and has been practiced
in many centers around the world (7). RF generator supplies
RF power to the tissue through the electrode and producing
RF voltage that producing electrical ﬁeld within the patient’s
body, this electric ﬁeld oscillates with alternating RF current
which cause oscillatory movements of ions in the tissue in pro-
portion to the ﬁeld intensity. The mechanism of tissue heating
for RF ablation is frictional, or resistive energy loss caused by
the motion from the ionic current (8).
Regardless of the method of treatment chosen, success is
highly dependent on pre-procedural localization of the nidus.
CT-guided RF procedure dramatically reduced morbidity
and complications compared with traditional open surgical
resection. Moreover it is usually carried out as an outpatient
procedure with less cost, medications and hospital stay (9).
In this study, we will highlight our work on 15 patients
referred to our institute, to treat them in a minimally invasive
outpatient fashion using CT guided RFA with much less mor-
bidity and no mortality compared to open surgical resection.
We will also describe in details our technique of performing
this procedure and the 12 months follow up post procedure.
2. Patients and methods
2.1. Patients
Between November 2009 and December 2012, 10 males and 5
females patients aged 12–35 (mean 20 years) with osteoid
osteoma were included in the study. Diagnosis was based onclinical suspicion conﬁrmed by plain radiography, MDCT,
MRI and bone scanning were needed in some cases.
Histopathological diagnosis was not obtained before treat-
ment. All patients were symptomatic at time of diagnosis,
and all of them were treated by percutaneous CT guided RF
ablation. The duration of pain before RF ablation varied from
several months to two years and some patients had limitation
of movement. The proximal femur and tibia were the common-
est sites involved. The mean maximum dimension of the
osteoid osteoma nidus was 7 mm (range, 3–12 mm), however
the degree of surrounding bone sclerosis and cortical thickness
was variable among patients, this was a crucial point predict-
ing technical difﬁculty during the procedure in how to punc-
ture the overlying cortex to reach the nidus.
The decision concerning appropriate treatment was made
by orthopedic surgeons and interventional radiologists on
the basis of clinical and radiological criteria. Clinical criteria
included pain that worsen at night and rest, and relief after
administration of non-steroidal anti-inﬂammatory drugs.
Radiological criteria included typical ﬁndings on radiographs
and CT and/or MRI with a clear depiction of a nidus, sur-
rounding bone sclerosis and increased thickness of the overly-
ing cortex at the typical site of patient complaint.
All the procedures were carried out in the CT suite after
administration of spinal or epidural anesthesia. The team
Fig. 1 (A and B) coronal CT images showing the nidus and the overlying bone sclerosis at the upper shaft of the femur. (C and D) Axial
CT images showing the nidus and the overlying bone sclerosis at the upper shaft of the femur.
CT guided radiofrequency ablation for osteoid osteoma 951consisted of an orthopedic surgeon, interventional Radiologist
and anesthesiologist. All patients rated their satisfaction with
the procedure after signing a written consent. All patients were
discharged within hours after the procedure and resumed full
weight-bearing. Follow-up was done every six months both
clinically for pain and by CT to monitor changes within the
ablated nidus. The next 6 months for architectural changes
of the lesion.
2.2. RF ablation procedure
Localization of the lesion was performed by immediate prepro-
cedure multiple thin-section CT images at the level of the
osteoid osteoma. Reformatted images were helpful for pre-
procedural planning. A single skin entry point was planned
for the lesion by putting Radiopaque marker on the skin over-
lying the lesion. Most of the lesions were approached from
anterior and lateral aspect to avoid medial vascular structures.
Spinal or epidural anesthesia was administered to all patients
during the procedure.
The patient lie supine on the CT couch (Bright speed 16
slice; GE medical system), ground bads are usually put at
the posterior aspect of the thigh. The skin then prepared anddraped with sterile technique. One gram of 3rd generation
cephalosporin was administered intravenously immediately
before the procedure.
A thin long Sheba needle was used to locate the lesion pass-
ing from the site of radiopaque skin marker reaching the outer
cortex of the osteoid osteoma guided by CT ﬂuoroscopy. Small
skin snip using scalpel was done then the Co-axial Bone biopsy
set was used to do percutaneous access to the lesion and guide
the RF electrode for ablation. Manual bone Drilling of the
cortex overlying the nidus was done, then CT images were
obtained many times during drilling to verify the depth and
direction of the bone drilling sheath in the nidus, when the drill
tip traversing the nidus reaching the contra lateral sclerosed
edge of the nidus, it was considered a satisfactory position
for placement of RF electrode.
The RF electrode was then inserted through the sheath of
the co axial system, with its tip directed toward the center of
the nidus reaching its contra lateral edge. CT images were
obtained again to conﬁrm appropriate position of the elec-
trode. Prior to ablation, the electrode hosting sheath was par-
tially withdrawn over the electrode out to the level of the
insulated shaft to prevent electrical conduction and heating
of adjacent tissues. The generator (RF 3000 Generator and
Fig. 2 Axial, coronal and 3D reformatted MDCT images showing the steps of CT guided RF ablation. (A) Showing bone drilling of the
overlying cortical sclerosis to reach the nidus. (B) Showing RF electrode tip passing through the overlying cortex and traversing the nidus
to the contra lateral side. (C) Coronal CT image showing proper position of the RF electrode within the nidus. (D) 3D reformatted image
showing the RF electrode passing to the target (nidus) from different plan.
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vated with an electrical impedance value of 200–600 X (10).
Thermal heating is applied with the RF electrode at a targeted
temperature of 90–105 C, with manual adjustment of output
controls during the procedure as needed to maintain a stable
lesion temperature and accepted tissue impedance. Ablation
is typically performed for a total of 5–7 min which may be
repeated in cycles as long as impedance was low, repositioning
of RF electrode tip in different directions was also performed
to insure more heat trapping, more ablation and much less
recurrence rate.
2.3. Post-procedural care
After ablation, the electrode is removed and a sterile dressing is
applied, no need for skin wound stitches. Discharge usually
within 4 h after the procedure. Weight bearing and prolonged
activity should be avoided for 1–3 months following the proce-
dure if ablation is performed in a weight-bearing bone (8,11).
A follow-up visit is scheduled 1 month after the procedure.
RF procedural success is deﬁned as the absence of pain after
the procedure during the follow up period. Follow-up CT is
only indicated 6 months post procedure.3. Results
The study was carried out at Radiology Department, El Minia
University Hospital, from November 2009 to June 2012.
Proximal femur and tibia were the commonest sites involved.
The selected group of patients included in the study were
symptomatic, presented by distressing pain not responding to
medications and seeking for deﬁnitive satisfactory treatment
option, all patients were diagnosed clinically and radiologically
as osteoid osteoma. 4 patients were satisﬁed by analgesics but
seeking for ablation to stop medications and avoiding side
effects of analgesics on GIT, 11 patients were not completely
responders to medication and developed tolerance to analgesic
doses they receive, 8 patients were suffering from limitation of
movement and reduced activity, 5 patients develop wasting
and reduction of muscle bulk in the affected limb and that
what force them for treatment (Table 1).
Treatment strategy was to perform the procedure in an out-
patient, complication free fashion with less cost, less hospital
stay and less morbidity. We achieved the goal in all patients
by following ﬁxed steps in assessment of all patients and their
lesions precisely as follow, ﬁrst step; patient suspected clini-
cally and referred from orthopedic department, then we
Fig. 3 Axial MDCT of a different patient showing the nidus and how is the CT images guiding RF electrode to the lesion. (A) Axial CT
image showing the nidus and the overlying cortical sclerosis. (B) Showing bone drilling tip going toward the cortex. (C) Axial CT image
showing RF electrode seen replacing the bone drilling sheath to the nidus. (D) Axial CT image showing how we advance the RF electrode
to take a good position within the nidus.
CT guided radiofrequency ablation for osteoid osteoma 953performed high quality digital radiographs for all patients,
which then conﬁrmed by MDCT (Bright speed 16 slice; GE
medical system), reformatted images were obtained for better
localization of the nidus and its overlying dense sclerosis and
cortical thickness. Location of the nidus was the most crucial
point for preoperative planning to perform the procedure
safely with less possible complication, MRI was done for
patients with suspicious lesions to asses related bone marrow
edema and soft tissue involvement in lesions of diagnostic
uncertainty (Table 2). Second step; good pre-operative plan-
ning by studying each lesion separately, the technique was cos-
tumed for each lesion based on its location and its relation to
the nearby vasculatures, moreover we followed ﬁxed steps of
CT guidance to reach the lesion and to achieve good ablation
by placing the RF electrode in a proper position within the
nidus to get the full beneﬁts of scientiﬁc fact ‘‘Oven effect’’
bone act as heat insulator, trapping of heat resulting in more
augmentation of heat effect and more tissue destruction
beyond what is expected (12). Technical success withoutintraoperative complications was achieved in 14 patients, in
one patient ground bad burn was surprisingly seen by the
end of the procedure, it was of ﬁrst degree burn and treated
completely within 10 days after the procedure, no hematoma
or fractures seen during the procedures in all patients. Third
step; postoperative care and follow up of patients for pain rel-
ive, 14 had prompt pain relief within 10 days and were able to
return to normal activities within 30–45 days after the proce-
dure. One patient had residual unrelieved pain and underwent
radiofrequency ablation within 3 months. By 6 months follow
up all patients had complete pain relive with no more medica-
tions used. Radiological healing in terms of reﬁlling (partial
ossiﬁcation) of the ablated cavity as well as reduction of bone
sclerosis and cortical thickness start to be apparent by the end
of ﬁrst 6 months (Table 3). There was no correlation between
pain relief and absence of the signs of radiological healing
(ossiﬁcation).
After a mean follow-up period of 6, 12 months no patient
had pain recurrence, more ever by being minimally invasive,
954 M.M.M. Elian, A.F. Sadekoutpatient procedure with less cost, less hospital stay and less
morbidity, dramatic pain relive with no recurrence, RF abla-
tion for osteoid osteoma will be superior to open surgery in
terms of pain control and better quality of life in a relatively
short time when compared to open surgical management (see
Figs. 1–3).
4. Discussion
Osteoid osteoma is a benign skeletal tumor, usually less than
1.5 cm in diameter, it is composed of woven bone, osteoid
and is more commonly located in the appendicular skeleton,
there is a male preponderance, with a male: female ratio of
3:1. It is commonly seen in children and young adults. The dis-
ease commonly presents with focal bone pain at the tumor site
in a child or a young adult. The pain has a characteristic pat-
tern; it worsens at night, increases with activity, and is relieved
by small doses of anti-inﬂammatory medications (13–15).
The ordinary open surgical treatment of osteoid osteoma
consists of en-bloc excision or curettage of the lesion. Several
alternative methods have been used recently, among which
CT guided-percutaneous radiofrequency ablation. In the view
of our results, CT-guided percutaneous RF ablation is a simple
minimally invasive, safe and effective technique for treatment
of osteoid osteoma and can be regarded as the treatment of
choice for most cases. Our results also suggest that RF abla-
tion represents a promising method for treating patients with
the persistent pain of osteoid osteoma shortly after the proce-
dure apart from pain of incision and the procedure itself which
subsides shortly. Open surgery should be reserved for cases of
diagnostic uncertainty, as well as for spinal lesions in a critical
locations, in which introduction of heat carry high risk of neu-
rological damage. In our series of 15 patients only one minor
complication was encountered and all patients returned to nor-
mal activity shortly post-operative.
We believe that the main challenge in CT-guided RF abla-
tion, as in other percutaneous techniques with a lack of histo-
logical evidence, is not the procedure itself, but the correct
selection of patients on the basis of imaging ﬁndings and symp-
toms, and that was avoided by joint consultation and evalua-
tion of all cases by both radiologists and the orthopedic
surgeons. Although the morphology of the lesion can vary
according to its location, most osteoid osteomas can be reli-
ably diagnosed by means of conventional radiographs,
MDCT and MRI (11).
Of the 15 patients, we did RFA twice for only one patient
that had recurrence and required a 2nd session of ablation.
The rest of patients were treated by single session of RF abla-
tion, we noticed the patient with recurrence had a lesion of
13 mm diameter. In a study done by Tilloston et al., they used
RFA in 8 patients with a lesion of 10 mm and more, they noted
a high recurrence rate in that group because these lesions were
ablated in multiple locations, using overlapping pattern of
ablation; it is likely that, in some areas of tumor outside the
sphere, ablation was not adequate and a residual viable tumor
tissue was the reason of tumor recurrence. Our electrode tip
was placed distally within the nidus, at different directions,
in different plans; multiple cycles of RF ablation were done
to get beneﬁts from ‘oven effect’. Lower thermal conductivity
of surrounding background bone (heat insulator) signiﬁcantly
increases temperatures within the nidus by accumulationand entrapment of heat to increase RF ablation efﬁcacy
(12,16).
RFA for bony tumors offers several advantages over other
treatment modalities, previously, surgical excision has been the
treatment of choice (17). Precise intraoperative localization of
the nidus is often difﬁcult and en-bloc excision often requires a
long incision, extensive dissection and frequently internal ﬁxa-
tion as a prophylaxis against fracture through the operative
site. Failure to locate the lesion at open excision is a well-
recognized complication (17), however with the advances in
CT technology precise CT ﬂuoroscopy guided localization of
the nidus during RFA reach 100% accuracy and incorrect tar-
geting is much less likely to occur in skilled hands. Another
treatment is CT-controlled laser photocoagulation, which has
been reported to give good results, but it requires expensive
equipment and complicated logistics (10). In our patients we
used manual drill by bone biopsy kit. CT-guided percutaneous
automatic drilling using a large-bore drill has also been
described (18).
Weight-bearing and return to ordinary life activity after
operation depend on the location of the lesion. One series
reported a complication rate of 24%, including two patients
with femoral neck fractures and one with osteomyelitis (18).
We have not encountered any major postoperative complica-
tions to date, and this result concurs with those of other studies
(19).
The interval to being symptom-free after therapy was vari-
able in our group. No patient was symptom-free at 24 h, it
took 3 days for our ﬁrst four patients to be symptom-free.
The remainders had complaint up to one 1 week post proce-
dure. This result can be compared with the results of two pub-
lished series of patients treated with RFA over a 4-min delivery
of energy at 90 C. The ﬁrst series included-18 patients, 10 of
them were symptom-free by 24 h; 14 were symptom-free by
3 days; and, ﬁnally, 16 patients were symptom-free by 1 week
(20). In the second series (13 patients), the number of
symptom-free patients at 24 h was not mentioned. By 3 days,
10 were symptom-free and one further patient was symptom-
free at 1 week (21).
5. Conclusion
Based on our experience RF ablation can be regarded as min-
imally invasive, safe alternative and superior to open surgery
in treatment of patients with osteoid osteoma with less mor-
bidity, mortality, cost and hospital stay.
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